TNFRSF10A and type 1 diabetes mellitus: The observation based large controls-cohort studies yields that the presence of SUMO4 GG increased further the relative risk conferred by HLA-DR3/DR4 to type 1 diabetes, whereas SUMO4 AA decreased the risk.